RxDoctor Payments Data

Jessica Howell

Family · Troy, MONPI 1669845681

Payments from drug & device makers

$2,443in general payments, 2019–2025

Across 128 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$746
  • Novo Nordisk$262
  • Pfizer$134
  • Dexcom, Inc.$134
  • Lilly USA, LLC$131
  • Vanda Pharmaceuticals Inc.$102
  • plus $935 from 24 others

What the payments were for

  • Food & beverage$2,443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,443 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$87,850
RexultiBrexpiprazole18$26,245
EliquisApixaban32$25,793
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$17,914
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$10,317
Incruse ElliptaUmeclidinium Bromide15$8,358
Atorvastatin Calcium264$2,443
Mometasone Furoate12$2,303
Albuterol Sulfate HfaAlbuterol Sulfate114$1,797
Gabapentin67$1,581
Omeprazole124$1,534
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,377
SynthroidLevothyroxine Sodium20$1,372
Oxybutynin Chloride ErOxybutynin Chloride33$788
Metformin Hcl ErMetformin Hcl57$770

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$262$87,85075 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$41$36,58952 claims
Otsuka America Pharmaceutical, Inc.Rexulti$41$26,24518 claims
PfizerEliquis$134$25,79332 claims
AbbVieSynthroid$746$1,37220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Troy

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →